School of Medicine Cancer & Hematology Clinical Trials

Menu Search
  • Home
  • Meet the Team
  • Forms
  • Useful Links
  • BU/BMC Cancer Center
  • BU/BMC Hematology & Medical Oncology
Search

Genitourinary

Kidney:

Central IRB #H-42652/ DFCI #21-575 (APART): A Phase 2 study of avelumab, axitinib and palbociclib in metastatic renal cell carcinoma (pending)

Cancer & Hematology Clinical Trials

  • Home
  • Meet the Team
  • Forms
  • Useful Links
  • BU/BMC Cancer Center
  • BU/BMC Hematology & Medical Oncology

Also See

  • BMC Cancer Support Programs
  • BU/BMC Amyloidosis Center